Skip to content

Menu

About Us
Our Science
Newsroom
- Press Releases
- Events & Presentations
Investor Relations
Contact

Close Menu

Our Science

Overview of Assets
Science
– Polyamines
– Polyamine Metabolic Inhibitor Technology
Pipeline
Clinical Trials
– Ivospemin
– Flynpovi
Expanded Access Policy

Quick Links

Home
About Us
Our Science
Newsroom
Investor Relations
Contact

Contact

ir@panbela.com

Sign up to receive press releases via email:

Leave this field empty if you're human:

News & Events

Panbela Announces Clinical Trial with Moffitt Cancer Center for Phase I/II Program in STK11 Mutant Non-Small Cell Lung Cancer

Panbela Provides Business Update and Reports Q1 2023 Financial Results

Panbela to Host First Quarter 2023 Earnings Conference Call on May 4, 2023

Copyright ©2023 Panbela Therapeutics, Inc. All Rights Reserved.